ACE2発現が高いことがコロナ感染に対していいのか悪いのかはcontroversy. この総説ではACE2善玉説の立場で論述。 加齢で肺ACE2減少、ACEI/ARBによるACE2発現増加はよいことかも、rhACE2投与が治療になるかもと記載。J Med Virol誌 #COVID19 https://t.co/UjAoNob3sn
Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Mar 2020 – Nov 2021Where it's discussed
-
X / Twitter11 posts
-
YouTube2 videos
-
News2 articles
AI synopsis
What people are saying
Discussions highlight the potential organ-protective effects of ACE2 in COVID-19, with posts mentioning medications like losartan and ARBs, and emphasizing the biological mechanisms involved. The tone reflects curiosity and recognition of the research's implications for ongoing treatment debates, demonstrating both active interest and moderate engagement.
Most discussions support the idea that ACE2 has a protective role in COVID-19, with some mentioning the potential benefits of medications like losartan and ARBs.
The posts show high interest, referencing specific drugs, mechanisms, and implications for treatment, indicating active engagement.
Several responses discuss the research details and its relevance to treatment strategies, reflecting a moderate depth of engagement.
Participants seem to believe that this research could influence clinical approaches, hinting at a notable impact on scientific and medical perspectives.
Abstract in brief
- The article discusses how ACE2, an important enzyme in the body's renin-angiotensin system, helps protect organs like the heart, lungs, and kidneys from damage and may influence the severity of COVID-19.
- Both SARS-CoV and the coronavirus SARS-CoV-2 use the ACE2 receptor to infect human cells, which can lead to severe lung issues like acute respiratory distress syndrome (ARDS), often associated with high mortality.
- Due to ACE2's protective roles, especially against conditions like hypertension and organ damage, developing vaccines and drugs that enhance ACE2 activity could be a promising strategy for treating COVID-19 in the future.]
Top posts
Most liked on X and BlueskySe sigue evaluando si el uso del losartan un medicamento para la hipertensión puede reducir las lesiones provocadas por el #COVIDー19 #coronavirus https://t.co/GcWxV3ocNw
Tiempo de seroconversión: IgM - 12 días IgG - 14 días No se relacionó con menor detección de ARN viral. No sólo respuesta humoral para combatir #COVID19. Artículo completo. Doi: 10.1002/jmv.25785
Organ-protective Effect of Angiotensin-converting Enzyme 2 and its Effect on the Prognosis of COVID-19. https://t.co/5PvsM6AAmC
Organ‐protective Effect of Angiotensin‐converting Enzyme 2 and its Effect on the Prognosis of COVID‐19 https://t.co/ClbN5un7NI
Journal of Medical Virology: "Organ‐protective effect of angiotensin‐converting enzyme 2 and its effect on the prognosis of COVID‐19" by Hao Cheng, Yan Wang, et al, March 27, 2020: https://t.co/8UbvdbOLHa
All mentions
Understanding COVID-19: Transmission and Complications
Neste vídeo, iremos falar sobre COVID-19, suas origens e modos de transmissão. Estudaremos ainda as complicações de coagulação, onde altos índices de trombose e sangramento foram observados. Aprofunde-se nos tratamentos…
Understanding COVID-19 Tests and Symptoms
This video explains COVID-19 transmission, symptoms, and how testing works, based on research from the University of Brasilia. It aims to provide a clear understanding of how COVID-19 is detected and its health impacts.
Se sigue evaluando si el uso del losartan un medicamento para la hipertensión puede reducir las lesiones provocadas por el #COVIDー19 #coronavirus https://t.co/GcWxV3ocNw
Journal of Medical Virology: "Organ‐protective effect of angiotensin‐converting enzyme 2 and its effect on the prognosis of COVID‐19" by Hao Cheng, Yan Wang, et al, March 27, 2020: https://t.co/8UbvdbOLHa
Interesante *amilorida* con o sin hidroxicloroquina en pacientes con SARS cov 2. Los ARA II son prometedores en COVID-19. Comment on “Organ‐protective Effect of Angiotensin‐converting Enzyme 2 and its Effect on the Prognosis of COVID‐19” https://t.co/TqHCpz9Ikr
RT @AREMIM4: Tiempo de seroconversión: IgM - 12 días IgG - 14 días No se relacionó con menor detección de ARN viral. No sólo respuesta humo…
Organ-protective Effect of Angiotensin-converting Enzyme 2 and its Effect on the Prognosis of COVID-19. https://t.co/5PvsM6AAmC
Tiempo de seroconversión: IgM - 12 días IgG - 14 días No se relacionó con menor detección de ARN viral. No sólo respuesta humoral para combatir #COVID19. Artículo completo. Doi: 10.1002/jmv.25785
ACE2発現が高いことがコロナ感染に対していいのか悪いのかはcontroversy. この総説ではACE2善玉説の立場で論述。 加齢で肺ACE2減少、ACEI/ARBによるACE2発現増加はよいことかも、rhACE2投与が治療になるかもと記載。J Med Virol誌 #COVID19 https://t.co/UjAoNob3sn
Trend new: *Cheng H* et al (J Med Virol) __Organ-protective Effect of Angiotensin-converting Enzyme 2 and its Effect on the Prognosis of COVID-19__ https://t.co/IZ3TygGWIZ
New article: Organ-protective Effect of Angiotensin-converting Enzyme 2 and its Effect on the Prognosis of COVID-19. https://t.co/amRjKlXGd0 #coronavirus #COVID19 #2019ncov
Organ‐protective Effect of Angiotensin‐converting Enzyme 2 and its Effect on the Prognosis of COVID‐19 https://t.co/ClbN5un7NI